Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome
Journal of Clinical Pharmacy and Therapeutics, 07/10/09
Barrons R et al. - Carbamazepine has demonstrated safety, tolerability and efficacy in treatment of moderate to severe symptoms of alcohol withdrawal in the inpatient setting. However, trials of carbamazepine provide inconclusive evidence for prevention of alcohol withdrawal seizures and DTs in comparison with benzodiazepines. Benzodiazepines remain the primary treatment of moderate to severe AWS.
Related Articles
A new understanding of why seizures occur with alcohol withdrawal
EurekAlert, 10/19/09
Relevance Score: 81%
Risk factors for delirium tremens in patients with alcohol withdrawal syndrome in a hospital setting
European Journal of Internal Medicine, 10/12/09
Relevance Score: 78%
Increased Acid Sphingomyelinase Activity in Peripheral Blood Cells of Acutely Intoxicated Patients With Alcohol Dependence
Alcoholism, 10/29/09
Relevance Score: 67%
Packages of Care for Alcohol Use Disorders in Low- And Middle-Income Countries
PLoS Medicine, 10/28/09
Relevance Score: 67%
Leisure-Time Physical Activity is Associated with a Reduced Risk for Metabolic Syndrome
Annals of Epidemiology, 10/13/09
Relevance Score: 67%
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials
BMC Infectious Diseases, 12/03/09
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
Malaria Journal, 12/01/09
Pharmacokinetic—pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide
Clinical Therapeutics, 12/01/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders
Journal of Dermatological Treatment , 12/04/09
Non-psoriatic dermatologic uses of monoclonal antibody therapy
Journal of Dermatological Treatment , 12/04/09
Does Simvastatin Cause More Myotoxicity Compared with Other Statins
Annals of Pharmacotherapy, 12/03/09
Sponsor
Article Search
Sponsor